Cargando…

Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI

PURPOSE: To evaluate the value of a browser-based PI-RADS Score Calculator (PCalc) compared to MRI reporting using the official PI-RADS v2.1 document (PDoc) for non-specialized radiologists in terms of reporting efficiency, interrater agreement and diagnostic accuracy for detection of clinically sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barth, Borna K., Martini, Katharina, Skawran, Stephan M., Schmid, Florian A., Rupp, Niels J., Zuber, Laura, Donati, Olivio F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930347/ https://www.ncbi.nlm.nih.gov/pubmed/33681427 http://dx.doi.org/10.1016/j.ejro.2021.100332

Ejemplares similares

Comparison of the PI-RADS 2.1 scoring system to PI-RADS 2.0: Impact on diagnostic accuracy and inter-reader agreement
por: Hötker, Andreas M., et al.
Publicado: (2020)

PI-RADS 2.1 und strukturierte Befundung der Magnetresonanztomographie der Prostata
por: Hötker, Andreas, et al.
Publicado: (2021)

Value of bowel preparation techniques for prostate MRI: a preliminary study
por: Schmidt, Cynthia, et al.
Publicado: (2021)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [(68)Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
por: Zhao, Jing, et al.
Publicado: (2020)

Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Impact of different phased-array coils on the quality of prostate magnetic resonance images
por: Stocker, Daniel, et al.
Publicado: (2021)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study)
por: Di Franco, Florian, et al.
Publicado: (2023)

Abbreviated MR Protocols in Prostate MRI
por: Hötker, Andreas M., et al.
Publicado: (2022)

Standards for MRI reporting—the evolution to PI-RADS v 2.0
por: Spektor, Michael, et al.
Publicado: (2017)

PI-RADS v2.1: What has changed and how to report
por: Scott, Robin, et al.
Publicado: (2021)

Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions
por: Brancato, Valentina, et al.
Publicado: (2021)

Improving workflow in prostate MRI: AI-based decision-making on biparametric or multiparametric MRI
por: Hötker, Andreas M., et al.
Publicado: (2021)

Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies
por: Wang, Yunhan, et al.
Publicado: (2023)

Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters
por: Woźnicki, Piotr, et al.
Publicado: (2020)

(68)Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement
por: Ferraro, Daniela A., et al.
Publicado: (2022)

Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
por: Li, Mou, et al.
Publicado: (2021)

Prostate MRI based on PI-RADS version 2: how we review and report
por: Steiger, Philipp, et al.
Publicado: (2016)

Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
por: Wang, Yu-Hao, et al.
Publicado: (2023)

Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy
por: Yang, Shuo, et al.
Publicado: (2020)

Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS
por: Radtke, Jan Philipp, et al.
Publicado: (2019)

Intraobserver and Interobserver Agreement between Six Radiologists Describing mpMRI Features of Prostate Cancer Using a PI-RADS 2.1 Structured Reporting Scheme
por: Jóźwiak, Rafał, et al.
Publicado: (2023)

The Diagnostic Value of PI-RADS v2.1 in Patients with a History of Transurethral Resection of the Prostate (TURP)
por: Liu, Jiazhou, et al.
Publicado: (2022)

Evaluation of the PI-RADS Scoring System for Classifying mpMRI Findings in Men with Suspicion of Prostate Cancer
por: Junker, Daniel, et al.
Publicado: (2013)

Efficacy of PI-RADS in prebiopsy prostate-MRI at a urological cancer centre: a comparison with histology
por: Patel, MD, et al.
Publicado: (2015)

MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
por: Schoots, Ivo G.
Publicado: (2018)

Joint Cancer Segmentation and PI-RADS Classification on Multiparametric MRI Using MiniSegCaps Network
por: Jiang, Wenting, et al.
Publicado: (2023)

Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
por: Brancato, Valentina, et al.
Publicado: (2020)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer
por: Singh, Dharmesh, et al.
Publicado: (2022)

Diagnostic performance of (68)Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
por: Ferraro, Daniela A., et al.
Publicado: (2021)

Alternative Functional rad21 Paralogs in Fusarium oxysporum
por: Pareek, Manish, et al.
Publicado: (2019)

An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines
por: Panebianco, Valeria, et al.
Publicado: (2017)

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
por: Viana, Publio Cesar Cavalcanti, et al.
Publicado: (2019)

Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification
por: Liu, Yongkai, et al.
Publicado: (2021)

Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy
por: Kornienko, Kira, et al.
Publicado: (2022)

Prostate Cancer Detection with mpMRI According to PI-RADS v2 Compared with Systematic MRI/TRUS-Fusion Biopsy: A Prospective Study
por: Sauck, Anja, et al.
Publicado: (2022)

Detection of ISUP ≥2 prostate cancers using multiparametric MRI: prospective multicentre assessment of the non-inferiority of an artificial intelligence system as compared to the PI-RADS V.2.1 score (CHANGE study)
por: Rouvière, Olivier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sk778k3ve54mms1ir34e2i9t3e